Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Risteli

Showing results (181-190 of 294) with videos related to

Pageof 30
Sort By:
Acta Endocrinologica|March 1, 1991
Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GHL T Jensen, J O Jørgensen, J Risteli, et al.
The American Review of Respiratory Disease|May 1, 1989
Malotilate prevents accumulation of type III pN-collagen, type IV collagen, and laminin in carbon tetrachloride-induced pulmonary fibrosis in ratsP Pääkkö, R Sormunen, L Risteli, et al.
Clinical Chemistry|April 1, 1988
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagenJ Risteli, S Niemi, P Trivedi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Complete processing of type III collagen in atherosclerotic plaquesM K Bode, M Mosorin, J Satta, et al.
Annals of Surgery|April 1, 1993
Collagen synthesis in intact skin is suppressed during wound healingL Ihlberg, K Haukipuro, L Risteli, et al.
Journal of the American Academy of Dermatology|December 1, 1994
Pachydermoperiostosis: analysis of the connective tissue abnormality in one familyA Oikarinen, R Palatsi, M Kylmäniemi, et al.
British Journal of Cancer|May 1, 1995
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancerT Kylmälä, T L Tammela, L Risteli, et al.
Rheumatology (Oxford, England)|April 25, 2006
Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritisM-K Koivula, S Aman, E Alasaarela, et al.
Acta Dermato-Venereologica|July 1, 1996
Increased collagen propeptides in the skin of a scleredema patient but no change in re-epithelialisation rateK M Haapasaari, M Kallioinen, K Tasanen, et al.
American Journal of Hematology|October 1, 1986
Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disordersH Hasselbalch, P Junker, I Lisse, et al.
Pageof 30

Showing results (181-190 of 294) with videos related to

Sort By:
Pageof 30
Acta Endocrinologica|March 1, 1991
Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GHL T Jensen, J O Jørgensen, J Risteli, et al.
The American Review of Respiratory Disease|May 1, 1989
Malotilate prevents accumulation of type III pN-collagen, type IV collagen, and laminin in carbon tetrachloride-induced pulmonary fibrosis in ratsP Pääkkö, R Sormunen, L Risteli, et al.
Clinical Chemistry|April 1, 1988
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagenJ Risteli, S Niemi, P Trivedi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Complete processing of type III collagen in atherosclerotic plaquesM K Bode, M Mosorin, J Satta, et al.
Annals of Surgery|April 1, 1993
Collagen synthesis in intact skin is suppressed during wound healingL Ihlberg, K Haukipuro, L Risteli, et al.
Journal of the American Academy of Dermatology|December 1, 1994
Pachydermoperiostosis: analysis of the connective tissue abnormality in one familyA Oikarinen, R Palatsi, M Kylmäniemi, et al.
British Journal of Cancer|May 1, 1995
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancerT Kylmälä, T L Tammela, L Risteli, et al.
Rheumatology (Oxford, England)|April 25, 2006
Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritisM-K Koivula, S Aman, E Alasaarela, et al.
Acta Dermato-Venereologica|July 1, 1996
Increased collagen propeptides in the skin of a scleredema patient but no change in re-epithelialisation rateK M Haapasaari, M Kallioinen, K Tasanen, et al.
American Journal of Hematology|October 1, 1986
Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disordersH Hasselbalch, P Junker, I Lisse, et al.
Pageof 30